These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The use of an angiotensin II antagonist (saralasin) as an adjunct during renal vein catheterization. Ibsen H, Giese J, Rabøl A, Kappelgaard AM. Scand J Clin Lab Invest; 1980 Apr; 40(2):115-20. PubMed ID: 7020064 [Abstract] [Full Text] [Related]
24. Role of the renin-angiotensin system in hypertension produced by unilateral renal artery constriction in the rat. Oates HF. Clin Exp Pharmacol Physiol; 1976 Apr; 3(1):95-8. PubMed ID: 971555 [Abstract] [Full Text] [Related]
25. [Kidney and hypertension]. Gross F. Klin Wochenschr; 1972 Jul 01; 50(13):621-35. PubMed ID: 4340139 [No Abstract] [Full Text] [Related]
26. Neurogenic activity--angiotensin II interaction during the development and maintenance of renal hypertension in the rat. Bellini G, Fiorentini R, Fernandes M, Onesti G, Hessan H, Gould AB, Bianchi M, Kim KE, Swartz C. Clin Sci (Lond); 1979 Jul 01; 57(1):25-9. PubMed ID: 477245 [Abstract] [Full Text] [Related]
27. Response to saralasin and angiotensin's role in essential and renal hypertension. Hollenberg NK, Williams GH, Adams DF, Moore T, Brown C, Borucki LJ, Leung F, Bavli S, Solomon HS, Passan D, Dluhy R. Medicine (Baltimore); 1979 Mar 01; 58(2):115-27. PubMed ID: 431398 [No Abstract] [Full Text] [Related]
30. [Saralasin for renovascular or essential hypertension (author's transl)]. Arlart I, Rosenthal J. Dtsch Med Wochenschr; 1978 Nov 10; 103(45):1790-6. PubMed ID: 710289 [No Abstract] [Full Text] [Related]
33. [Effects of angiotensin II analogue on rabbits with acute and chronic two-kidney, one clip hypertension (author's transl)]. Yamasaki S, Nakatani H, Kusunoki K, Kawashima T, Kawamura H, Ohara T, Shintani H, Taniguchi N, Nagai T. Nihon Jinzo Gakkai Shi; 1979 Nov 10; 21(11):1251-63. PubMed ID: 396405 [No Abstract] [Full Text] [Related]
34. [Blood pressure behavior following 1-sar-8-ala-angiotensin II (saralasin) in essential and renovascular hypertension]. Rosenthal J, Franz HE. Verh Dtsch Ges Inn Med; 1976 Nov 10; 82 Pt 2():1305-7. PubMed ID: 1029984 [No Abstract] [Full Text] [Related]
35. Saralasin infusion in the recognition of renovascular hypertension. Wilson HM, Wilson JP, Slaton PE, Foster JH, Liddle GW, Hollifield JW. Ann Intern Med; 1977 Jul 10; 87(1):36-42. PubMed ID: 879617 [Abstract] [Full Text] [Related]
36. Reciprocation of renin dependency with sodium volume dependency in renal hypertension. Gavras H, Brunner HR, Thurston H, Laragh JH. Science; 1975 Jun 27; 188(4195):1316-7. PubMed ID: 1145199 [Abstract] [Full Text] [Related]
37. Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation. Brunner HR, Gavras H, Laragh JH. Prog Cardiovasc Dis; 1974 Jun 27; 17(2):87-98. PubMed ID: 4369198 [No Abstract] [Full Text] [Related]
38. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension. Marks LS, Maxwell MH, Kaufman JJ. Ann Intern Med; 1977 Aug 27; 87(2):176-82. PubMed ID: 889198 [Abstract] [Full Text] [Related]
39. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects]. Beyer J, Liebau G, Steiner B, Schick K, Hayduk K. Verh Dtsch Ges Kreislaufforsch; 1977 Aug 27; 43():212-3. PubMed ID: 613577 [No Abstract] [Full Text] [Related]
40. [Effects of saralasin on 20 hypertensive patients (author's transl)]. Plaza de los Reyes M, Passalacqua W, Plaza de los Reyes X, Pla C, Campino C. Rev Med Chil; 1980 Feb 27; 108(2):115-20. PubMed ID: 7017869 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]